Profil
Sophie Binay is currently the General Manager & Chief Scientific Officer at Acticor Biotech SAS. She previously worked as the Director-Nonclinical Research & Development at Minka Therapeutics SA, the VP-Research & Early Clinical Development at PEP-Therapy SAS, and the Head-Translational Programs at Gustave Roussy Institute.
Aktive Positionen von Sophie Binay
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTICOR BIOTECH | Technik-/Wissenschafts-/F&E-Leiter | 15.06.2021 |
Ehemalige bekannte Positionen von Sophie Binay
| Unternehmen | Position | Ende |
|---|---|---|
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Technik-/Wissenschafts-/F&E-Leiter | - |
Gustave Roussy Institute | Corporate Officer/Principal | - |
PEP-Therapy SAS
PEP-Therapy SAS BiotechnologyHealth Technology biotechnology development and research. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops a portfolio of therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS | Health Technology |
PEP-Therapy SAS
PEP-Therapy SAS BiotechnologyHealth Technology biotechnology development and research. | Health Technology |
Acticor Biotech SAS
Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
Gustave Roussy Institute |
















